Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.
about
Patterns of Chromosomal Aberrations in Solid TumorsThe consequences of chromosomal aneuploidy on the transcriptome of cancer cellsUDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.Inherent variability of cancer-specific aneuploidy generates metastasesMutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas.HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell nicheCell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.Comparison of Nanostring nCounter® Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.A latent variable approach for meta-analysis of gene expression data from multiple microarray experimentsArtificially introduced aneuploid chromosomes assume a conserved position in colon cancer cellsDATE analysis: A general theory of biological change applied to microarray data.A gene expression classifier of node-positive colorectal cancerComparability of microarray data between amplified and non amplified RNA in colorectal carcinoma.Can survival prediction be improved by merging gene expression data sets?The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliabilityConsensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studiesMetastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerTissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing.A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer.The high mobility group A1 molecular switch: turning on cancer - can we turn it off?Copy number alterations and allelic ratio in relation to recurrence of rectal cancerSpontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances.The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genomeGenetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer.An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancerThe Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancerClinical applications of gene expression in colorectal cancer.Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.Chromosomal copy number changes of locally advanced rectal cancers treated with preoperative chemoradiotherapyPreoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence.Next generation sequencing and a new era of medicine.LGR5 positivity defines stem-like cells in colorectal cancer.Effects of aneuploidy on gene expression: implications for cancer.
P2860
Q26786127-AB0C3D82-7693-49E1-994A-D59F91C8A0ADQ26995532-6D9E8DF5-08C8-42B8-B980-48418447B7C1Q27853065-DF57A476-E642-43E5-B8BD-AE6AD1BB7ED3Q28817229-0997E061-0D30-47CF-9A62-FC83199B02D5Q30531068-4D4F114D-B813-4A58-9FCF-CDE8F83B7DFBQ30847630-8F305BCB-5165-46C7-AE5B-87FDC35802FCQ31016728-4FD807BE-3C83-418D-9797-295D13C5E315Q31095892-6B5585E9-7FCE-4541-966D-5D6F18A939BDQ31131323-1C85B51F-7A7A-4221-94B5-DEA1B7C7CF52Q33276412-09FD9540-FA90-4431-85CB-102CE77739F7Q33494114-9AB0437A-A250-4BE8-BDFB-C2CB1B7DA677Q33507915-1CB3FE0A-D5D4-4DD5-A453-C5224746743CQ33510352-819C4AA4-6001-4F66-8CE2-735FEB7E2540Q33511962-FE2873CE-A461-491D-A92D-3C622F0E5D21Q33613335-5FFC8486-16E9-4501-B230-43B941E6AD78Q33721845-FFDC93D6-9E0F-4EC3-BED1-C9845D5902BEQ33889157-CCF6600D-38E2-4515-8840-6E78E38EC59EQ34062558-3F3059EA-5D0A-4BA6-A4C3-07D883D7A5A0Q34202435-8F0AC285-5A4F-414E-9A71-EE95DF755214Q34384230-C03825EA-632F-43AA-828C-8FE7A560CC0EQ34433320-4569A834-F16C-4B52-9C5A-23A1A25FAC45Q34787147-08588DB9-D21D-44D6-9C1A-F0DF6AF5BE37Q35009536-8F469FA4-031B-4053-B1BC-199F1AC39A9BQ35012509-569D91EB-2532-409E-8BB1-21853DA2FC11Q35504403-F769C5FF-A128-4BF3-A6D0-A52E31847B0EQ35655094-2BD3EE5C-4F8B-48FD-A73B-59EF0CE375D0Q35748478-FD6D77F1-11F9-459C-ADBE-07DDB8B88901Q35859128-E04AA922-41D1-4BDD-BCA5-ED8E38536F3BQ36509335-B918D2B2-EAED-4422-B7BC-7D4133D59EF9Q36509342-6EDAD3B1-2238-42B1-B178-3D8614EC57C6Q36544900-6379B139-1F88-432A-9E5C-AE3DC2B802FCQ36739216-6334592E-D56C-4E96-8FA2-13BCC7C95ADBQ36792372-0CD71336-BD5A-4E3E-929D-1187D0DEC12DQ37141149-8D28AFBB-CCEB-4F57-8D96-6D5D3EC5A3ECQ37206514-30CA0CF7-2B7C-4552-9959-13D1055FC7D2Q37271984-5A7ED9D9-0D0A-46A2-8CA1-2A5AE84F27EBQ37398630-1886DC1F-B04E-42F6-8256-20B175AD5AF8Q37409165-56225587-2391-4B27-BDB2-ACC7FEA6860DQ37687330-4AE1977F-A284-4260-8A5A-FB356F827235Q38629879-F3C50D86-EAA8-4A3F-BBC6-2623FED1D316
P2860
Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Gene expression profiling reve ...... ode-positive colon carcinomas.
@ast
Gene expression profiling reve ...... ode-positive colon carcinomas.
@en
type
label
Gene expression profiling reve ...... ode-positive colon carcinomas.
@ast
Gene expression profiling reve ...... ode-positive colon carcinomas.
@en
prefLabel
Gene expression profiling reve ...... ode-positive colon carcinomas.
@ast
Gene expression profiling reve ...... ode-positive colon carcinomas.
@en
P2093
P2860
P1433
P1476
Gene expression profiling reve ...... ode-positive colon carcinomas.
@en
P2093
Amanda B Hummon
B Michael Ghadimi
Danny Wangsa
Heinz Becker
Marian Grade
Michael J Difilippantonio
Patrick Hörmann
Richard Simon
Sandra Becker
Sudhir Varma
P2860
P356
10.1158/0008-5472.CAN-06-1514
P407
P577
2007-01-01T00:00:00Z